cardinal health glp-1 receptor agonist weight management diabetes treatments Beyond Agonists: An Adaptive Ketogenic–Mediterranean Protocol to Counter Metabolic Adaptation in Obesity GLP-1 Receptor Agonists for the

Compared with nonusers, adults taking GLP-1s had a: 17 percent lower risk of venous thromboembolism, or blood clots in the veins 31 percent lower risk of pulmonary embolism, a potentially life-threatening clot that travels to the lungs 21 percent lower risk of going to the emergency department 44 percent lower risk of all-cause mortality (death from any cause) Researchers also observed lower stroke rates among GLP-1 users, although this difference didnt reach statistical significance

Federal Drug Administration have received reports of adverse events, some including hospitalizations on compounded GLP-1 drugs due to dosing errors or incorrect doses with self-administration

Angarita GA, Matuskey D, Pittman B, Costeines JL, Potenza MN, Jastreboff AM, et al

The STEP-9 trial showed patients with knee osteoarthritis taking semaglutide experienced marked improvements in pain scores along with significant weight reduction 39